Organ Preservation Market - Global Industry Analysis

Organ Preservation Market By Technique (Static Cold Storage, Hypothermic Perfusion Preservation And Other Techniques), By Preservation Solution (Viaspan, Custodiol HTK, Renograf, Perfadex, Human Biosystem (HBS) Solution, Lifor And Others) For Kidney, Lung, Liver, Heart And Other Organs: Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028.

Published Date: 30-Jun-2021 Category: Biotechnology Report Format : PDF Pages: 154 Report Code: ZMR-1250 Status : Published

The global Organ Preservation market accounted for USD 229.1 Million in 2020 and is expected to reach USD 360.8 Million by 2028, growing at a CAGR of 5.6% from 2021 to 2028.

Description

Market Overview   

The global Organ Preservation market accounted for USD 229.1 Million in 2020 and is expected to reach USD 360.8 Million by 2028, growing at a CAGR of 5.6% from 2021 to 2028.  

The major boosters for the organ preservation market comprise increasing solid organ transplantation processes. Moreover, the rising aged population everywhere on the planet paired with increasing multi-organ breakdown incidences is additionally likely to bolster the organ preservation market in years to return.  Additionally to the present, rising government initiatives to support organ donation also will power the event of the organ preservation market. On the opposite hand, limited scope at the extent of end-users and therefore the high price of purchase are likely to hinder the expansion of the organ preservation market in coming years.

Despite these limitations, R&D within the organ preservation market is probably going to be a catalyst for the organ preservation market shortly. For instance, in July 2015, UW Hospital invented a replacement organ preservation method that will replace UW Solution, thereby towering the organ preservation market.

COVID-19 Impact Analysis:

Besides, the COVID-19 outbreak, there's a drastic increase in the demand for medical facilities across the world. The increasing corona cases across the world are forcing governments of developed and emerging countries to extend their patient management capacities. COVID-19 has delayed and disrupted the treatment of many patients with organ replacement, however, healthcare management along with the government are planning well to overcome the situation or to manage the treatment of organ replacement amid the pandemic. The improvement in the organ preservation process is another major factor that will positively impact the market growth.

Growth Factors

The growth of the organ preservation market is mainly driven by the increasing incidence of the growing geriatric population, multi-organ failure, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview

Based on technique the organ preservation market is segmented into static cold storage (SCS), hypothermic perfusion preservation (HPP) and others. By technique, the segment witnessed a big market share of Static cold storage in 2018. This system is employed for the preservation of the kidneys, liver, lung, pancreas, and heart. The low cost and requirements of SCS ensure its adoption among end-users. The benefits of normothermic machine perfusion provide its high rate of growth within the solutions market within the forecast period of 2021 to 2028.

Based on preservation solution the organ preservation market is segmented into Viaspan, Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution, Renograf, Perfadex, Human bioSystem (HBS) Solution, Lifor, and Others. Perfadex solution is widely used for the preservation and perfusion of Lungs, making it the gold standard for lung storage. UW solution accounts for the very best share in 2019. It is used for the flushing and storage of kidneys, liver, and pancreas.

Based on organ type the organ preservation market is segmented into kidneys, lung, liver, heart, and other organs. The demand for lungs is expected to grow at a faster rate in the period of 2021 to 2028, mainly due to the rising prevalence of COPD and other target diseases & disorders necessitating lung transplantation. The kidney established a significant market share in 2020.

 

Regional Analysis Preview

North America held the most important market share in 2018 and is predicted to take care of its dominance over the forecast period. Rising acceptance of innovative healthcare technologies, high prevalence of chronic kidney diseases and coronary failure, better reimbursement policies, and increasing investments for improving healthcare infrastructure are the main factors promoting the expansion. Furthermore, the rising geriatric population and an increasing number of organ transplantation procedures also are expected to market the regional market growth.

Key Market Players & Competitive Landscape

Major players active in the global Organ Preservation market are BioLife Solutions, Inc., BioTime, Inc., Claris Lifesciences Limited, CryoLife, Inc., Bristol-Myers Squibb, Lifeline Scientific, Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Preservation Solutions, Inc., ToleroTech, Inc., among others. These players are set to foster the development of global Organ Preservation market in the forecast market.

The global Organ Preservation  market is segmented as follows:   

By Technique

  • Static Cold Storage (SCS)
  • Hypothermic Perfusion Preservation (HPP)
  • Others

By Solution

  • Viaspan
  • Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution
  • Renograf
  • Perfadex
  • Human bioSystem (HBS) Solution
  • Lifor
  • Others

By Organ Type

  • Kidneys 
  • Lung
  • Liver
  • Heart
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Technique
        • 2.1.1.2. Market Attractiveness Analysis, By Sulution
        • 2.1.1.3. Market Attractiveness Analysis, By Type
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Organ Preservation Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Organ Preservation Market – Technique Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Technique, 2020 & 2028
    • 4.2. Static Culd Storage (SCS)
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Hypothermic Perfusion Preservation (HPP)
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Others
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Organ Preservation Market – Sulution Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Sulution, 2020 & 2028
    • 5.2. Viaspan
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Custodiul HTK – (Histidine-Tryptophan-Ketoglutarate) Sulution
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Renograf
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Perfadex
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Human bioSystem (HBS) Sulution
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Lifor
      • 5.7.1. Market Size and Forecast, By Region (USD Million)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Others
      • 5.8.1. Market Size and Forecast, By Region (USD Million)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Organ Preservation Market – Type Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Type, 2020 & 2028
    • 6.2. Kidneys
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Lung
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Liver
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Heart
      • 6.5.1. Market Size and Forecast, By Region (USD Million)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.6. Others
      • 6.6.1. Market Size and Forecast, By Region (USD Million)
      • 6.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Organ Preservation Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Technique, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Sulution, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Type, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Technique, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Sulution, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Type, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Technique, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Sulution, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Type, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Technique, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Sulution, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Type, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Technique, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Sulution, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Type, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Technique, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Sulution, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Type, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Technique, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Sulution, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Type, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Technique, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Sulution, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Type, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Technique, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Sulution, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Type, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Technique, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Sulution, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Type, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Technique, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Sulution, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Type, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Technique, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Sulution, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Type, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Technique, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Sulution, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Type, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Technique, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Sulution, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Type, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Technique, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Sulution, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Type, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Technique, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Sulution, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Type, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Technique, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Sulution, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Type, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Technique, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Sulution, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Type, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Technique, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Sulution, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Type, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Technique, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Sulution, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Type, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Technique, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Sulution, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Type, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Technique, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Sulution, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Type, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Technique, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Sulution, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Type, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Technique, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Sulution, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Type, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Technique, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Sulution, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Type, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Technique, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Sulution, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Type, 2016 – 2028
  • Chapter No. 8 Organ Preservation Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Organ Preservation Market: Company Market Share, 2019
      • 9.1.2. Global Organ Preservation Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Organ Preservation Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Organ Preservation Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Biulife Sulutions, Inc.
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. BioTime, Inc.,
    • 10.3. Claris Lifesciences Limited
    • 10.4. Cryulife, Inc.
    • 10.5. Bristul-Myers Squibb
    • 10.6. Lifeline Scientific
    • 10.7. Dr. Franz Köhler Chemie GmbH
    • 10.8. Teva Pharmaceutical Industries Ltd.
    • 10.9. Preservation Sulutions, Inc.
    • 10.10. TuleroTech, Inc.
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Technique
FIG NO. 2. Market Attractiveness Analysis, By Solution
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Organ Preservation  Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Technique, 2020 & 2028
FIG NO. 8. Global Organ Preservation  Market for Static Cold Storage (SCS), Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Organ Preservation  Market for Static Cold Storage (SCS), By Country, 2020 & 2028
FIG NO. 10. Global Organ Preservation  Market for Hypothermic Perfusion Preservation (HPP), Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Organ Preservation  Market for Hypothermic Perfusion Preservation (HPP), By Country, 2020 & 2028
FIG NO. 12. Global Organ Preservation  Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Organ Preservation  Market for Others, By Country, 2020 & 2028
FIG NO. 14. Market Revenue Share, By Solution, 2020 & 2028
FIG NO. 15. Global Organ Preservation  Market for Viaspan, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Organ Preservation  Market for Viaspan, By Country, 2020 & 2028
FIG NO. 17. Global Organ Preservation  Market for Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Organ Preservation  Market for Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution, By Country, 2020 & 2028
FIG NO. 19. Global Organ Preservation  Market for Renograf, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Organ Preservation  Market for Renograf, By Country, 2020 & 2028
FIG NO. 21. Global Organ Preservation  Market for Perfadex, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Organ Preservation  Market for Perfadex, By Country, 2020 & 2028
FIG NO. 23. Global Organ Preservation  Market for HBS, Revenue (USD Million) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Organ Preservation  Market for HBS, By Country, 2020 & 2028
FIG NO. 25. Global Organ Preservation  Market for Lifors, Revenue (USD Million) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Organ Preservation  Market for Lifors, By Country, 2020 & 2028
FIG NO. 27. Global Organ Preservation  Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Organ Preservation  Market for Others, By Country, 2020 & 2028
FIG NO. 29. Market Revenue Share, By Type, 2020 & 2028
FIG NO. 30. Global Organ Preservation  Market for Kidneys, Revenue (USD Million) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Organ Preservation  Market for Kidneys, By Country, 2020 & 2028
FIG NO. 32. Global Organ Preservation  Market for Lung, Revenue (USD Million) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Organ Preservation  Market for Lung, By Country, 2020 & 2028
FIG NO. 34. Global Organ Preservation  Market for Liver, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Organ Preservation  Market for Liver, By Country, 2020 & 2028
FIG NO. 36. Global Organ Preservation  Market for Heart, Revenue (USD Million) 2016 – 2028
FIG NO. 37. Comparative Revenue Analysis of Organ Preservation  Market for Heart, By Country, 2020 & 2028
FIG NO. 38. Global Organ Preservation  Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 39. Comparative Revenue Analysis of Organ Preservation  Market for Others, By Country, 2020 & 2028
FIG NO. 40. Global Organ Preservation  Market Revenue Share, By Region, 2020 & 2028
FIG NO. 41. North America Organ Preservation  Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 42. Porter’s Five Forces Analysis for Global Organ Preservation  Market
FIG NO. 43. PEST Analysis for Global Organ Preservation  Market
FIG NO. 44. Pricing Analysis for Global Organ Preservation  Market
FIG NO. 45. Value Chain Analysis for Global Organ Preservation  Market
FIG NO. 46. Company Share Analysis, 2019
FIG NO. 47. Radar Determinant Chart, 2019
FIG NO. 48. Company Strategic Developments – Heat Map Analysis
FIG NO. 49. STMicroelectronics NV Business Segment Revenue Share, 2020 (%)
FIG NO. 50. STMicroelectronics NV Geographical Segment Revenue Share, 2020 (%)
FIG NO. 51. Market Channels
FIG NO. 52. Marketing Channel Development Trend
FIG NO. 53. Growth in World Gross Product, 2008-2018
FIG NO. 54. Research Methodology – Detailed View
FIG NO. 55. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Organ Preservation  Market: Snapshot
TABLE NO. 2. Quarterly Organ Preservation  Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Organ Preservation  Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Organ Preservation  Market for Static Cold Storage (SCS), by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Organ Preservation  Market for Hypothermic Perfusion Preservation (HPP), by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Organ Preservation  Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Organ Preservation  Market for Viaspan, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Organ Preservation  Market for Custodiol HTK – (Histidine-Tryptophan-Ketoglutarate) Solution, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Organ Preservation  Market for Renograf, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Organ Preservation  Market for Perfadex, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Organ Preservation  Market for HBS, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Organ Preservation  Market for Lifor, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Organ Preservation  Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Organ Preservation  Market for Kidneys, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Organ Preservation  Market for Lung, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Organ Preservation  Market for Liver, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19. Global Organ Preservation  Market for Heart, by Region, 2016 – 2028 (USD Million)
TABLE NO. 20. Global Organ Preservation  Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 21. Global Organ Preservation  Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 22. Global Organ Preservation  Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Organ Preservation  Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 24. North America Organ Preservation  Market Revenue, By Technique, 2016 – 2028 (USD Million)
TABLE NO. 25. North America Organ Preservation  Market Revenue, By Solution, 2016 – 2028 (USD Million)
TABLE NO. 26. North America Organ Preservation  Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 27. U.S. Organ Preservation  Market Revenue, By Technique, 2016 – 2028 (USD Million)
TABLE NO. 28. U.S. Organ Preservation  Market Revenue, By Solution, 2016 – 2028 (USD Million)
TABLE NO. 29. U.S. Organ Preservation  Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 30. Canada Organ Preservation  Market Revenue, By Technique, 2016 – 2028 (USD Million)
TABLE NO. 31. Canada Organ Preservation  Market Revenue, By Solution, 2016 – 2028 (USD Million)
TABLE NO. 32. Canada Organ Preservation  Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 33. Mexico Organ Preservation  Market Revenue, By Technique, 2016 – 2028 (USD Million) 
TABLE NO. 34. Mexico Organ Preservation  Market Revenue, By Solution, 2016 – 2028 (USD Million)
TABLE NO. 35. Mexico Organ Preservation  Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 36. Drivers for the Organ Preservation  Market: Impact Analysis
TABLE NO. 37. Restraints for the Organ Preservation  Market: Impact Analysis
TABLE NO. 38. Major Buyers of Organ Preservation 
TABLE NO. 39. Distributors/Traders List of Organ Preservation  
TABLE NO. 40. Global Organ Preservation  Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 41. Global Organ Preservation  Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 
 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Organ preservation market. Zion Research has collected and analyzed key data belong to the global Organ preservation market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Organ preservation across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Organ preservation industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases, and market reports

News articles, press releases, and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Organ preservation market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage, and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Global organ preservatives market is expected to witness a significant growth owing to increasing number of patients waiting for an organ transplant and rising incidences of vital organ failure (kidney, lungs, heart and etc.). The rising number of opportunities through strategic partnership with research organizations and medical institutions is projected to help the prominent players in expanding their consumer base.

Major driving factors are rising multi-organ failure cases in the aging population, rising solid organ transplantation procedures and increasing government initiatives to promote organ donation. In addition, the growing focus on advancements in the medical sector is likely to contribute widely towards the development of the overall market in the next few years. Also, increasing age population will fuel the growth of organ preservation solutions market, due to the reason that the risk of organ failure in elderly people increases which supplements the demand for organ transplants.  However, the limited medical reimbursements for organ transplantation and donation and the high cost of transplants are estimated to curb the growth of the overall market in the next few years.

Global-Organ-Preservation-Market

On the basis of technique, the global organ preservatives market is categorized into; static cold storage (SCS), hypothermic perfusion preservation (HPP) and others. In this segment, static cold storage dominated the market by accounting for the largest share in 2016, owing to better long-term graft survival rates. However, hypothermic perfusion preservation technique is expected to witness the fastest growth in coming five years. It involves the machine profusion which provides a better short-term outcome, with lower rates of delayed graft function after transplantation of kidneys from all types of deceased donors. Therefore, interest in machine perfusion is increasing. In addition, it allows the continuous supply of solution to the preserved organ.

On the basis of preservation solution, the organ peservatives market segment is categorized into viaspan, custdiol HTK – (histidine-tryptophan-ketoglutarate) solution, renograf, perfadex, human biosystem (HBS) solution, lifor and others.

Custdiol HTK is preferred in organ preservative solutions due to its properties such as; rapid homogenous cooling due to low viscosity and easier surgical handling due to excellent visibility.  In addition, other properties include; the strong buffer (histidine), osmotic barrier (mannitol) and low-permeable amino acids (tryptophan and alpha-ketoglutaric acid) which help to stabilize cell membranes and may be substrates for anaerobic metabolism. Furthermore, the low viscosity of HTK solution provides more effective flushing and rapid cooling of organs.

On the basis of the organ type global organ preservation market is segmented into kidney lung, liver, heart and other organs. In this segment, kidney preservation attributed for the largest share owing to the increasing prevalence of kidney failures. As per American kidney fund, in 2015, Kidney disease is the 9TH leading cause of death in the United States. An estimated 31 million people in the United States (10% of the adult population) have chronic kidney disease (CKD).

North America accounted for largest share of this market in 2016 and is expected to witness the fastest growth in global organ peservatives market in coming five years. Growth in this region for this market is attributed to increasing awareness about organ donation resulting in an increase in organ donors. In addition, research and development in organ preservation solutions are also expected to fuel the growth in this market in this region.

Europe is expected to be followed by North America and is expected to gain the second largest share in this market within the forecast period. The increasing awareness regarding the need for organ donation among the people and the rising number of initiatives taken by the government to encourage organ donation are expected to supplement the market growth in this region within the forecast period. In addition, the significant contribution from Spain is also expected to foster the growth of the market in the coming five years.

Asia-Pacific is expected to witness the fastest growth in this market in next five years. Growth in this region is expected to accelerate by increasing healthcare spending and increasing the aging population. Latin America and the Middle East & South Africa is also expected to show a positive growth in coming five years. In Latin America, a significant contribution from Brazil due to the increasing number of deceased and living organ donor is also expected to foster the growth of the market in the coming five years.

Some of the key players of green building market such as BioLife Solutions, Inc., BioTime, Inc., Claris Lifesciences Limited, CryoLife, Inc., Bristol-Myers Squibb, Lifeline Scientific, Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Preservation Solutions, Inc., ToleroTech, Inc., among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Organ Preservation market was valued at USD 229.1 Million in 2020.

The global Organ Preservation market is expected to reach USD 360.8 Million by 2028, growing at a CAGR of 5.6% between 2021 to 2028.

The demand is on a rise owing to the increasing cases of organ failure across the globe, initiatives encouraging organ donation, geriatric population, and the presence of key players in developing and developed countries. 

Regionally, North America has been leading the worldwide Organ Preservation market and is anticipated to continue in the dominant position in the years to come.

Major players active in the global Organ Preservation market are BioLife Solutions, Inc., BioTime, Inc., Claris Lifesciences Limited, CryoLife, Inc., Bristol-Myers Squibb, Lifeline Scientific, Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Preservation Solutions, Inc., ToleroTech, Inc., among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed